| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |
| 01/25/2005 | US6846828 Aminopyrimidine and aminopyridine anti-inflammation agents |
| 01/25/2005 | US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents |
| 01/25/2005 | US6846820 For therapy of diabetes, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemias, hyperlipidemia, atherosclerosis and myocardial ischemia in mammals |
| 01/25/2005 | US6846819 Bactericides compound containing acrylamide group |
| 01/25/2005 | US6846818 Selective inhibitors of cyclooxygenase-2 |
| 01/25/2005 | US6846815 Heterocyclic imines such as 2-anilino-6-quinoxalinol, used to suppress cell proliferation, differentiation, chemotaxis and/or activation; prophylaxis of restinosis; anticarcinogenic agents |
| 01/25/2005 | CA2103383C Quinazoline derivatives |
| 01/20/2005 | WO2005005428A1 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 01/20/2005 | WO2005005416A1 Pyrrole-2, 5-dithione derivatives as liver x receptor modulators |
| 01/20/2005 | WO2005005415A1 Indoles useful in the treatment of inflammation |
| 01/20/2005 | WO2005005414A2 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 01/20/2005 | WO2005005397A1 5-substituted quinazolinone derivatives |
| 01/20/2005 | WO2005005395A2 Arylamine-substituted quinazolinone compounds |
| 01/20/2005 | WO2005005393A2 Cck-1 receptor modulators |
| 01/20/2005 | WO2005005392A1 Azacyclic compounds as inhibitors of sensory neurone specific channels |
| 01/20/2005 | WO2005005386A1 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 01/20/2005 | WO2005005378A2 Indolinone hydrazides as c-met inhibitors |
| 01/20/2005 | WO2005004863A1 Benzimidazole carboxamides as raf kinase inhibitors |
| 01/20/2005 | WO2005004801A2 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives |
| 01/20/2005 | WO2004100865A3 New benzimidazole derivatives |
| 01/20/2005 | WO2004080390A3 Antiprotozoal imidazopyridine compounds |
| 01/20/2005 | WO2004069793A3 Novel 2-substituted cyclic amines as calcium sensing receptor modulators |
| 01/20/2005 | WO2004069158A3 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 01/20/2005 | US20050014942 Transforming growth factor inhibitor; controllign cell differentiation, cell proliferation |
| 01/20/2005 | US20050014939 E.g., N-[4-(2-Pyrrolidinylethoxy)phenyl]-4-oxo-4,5,6,7-tetrahydro-1H-indole-3-carboxamide; treating diseases associated with pathogenic agonism, inverse agonism or antagonism of the GABAA receptor such as anxiety, depression, a sleep disorder, or cognitive impairment |
| 01/20/2005 | US20050014938 Phenyl substituted triazoles and their use as selective inhibitors of akl5 kinase |
| 01/20/2005 | US20050014815 Substituted 2-pyrrolidine-2-yl-1H-indole compounds |
| 01/20/2005 | US20050014811 Such as 4-cyclopentylamino-benzenesulfonic acid 2-(3,4-dimethoxy-phenylamino)-1H-benzoimidazol-5-yl ester; cyclin-dependent kinase inhibitors that are aimed to be more active than flavopiridol |
| 01/20/2005 | US20050014805 Hypotensive agents; antidiabetic agents; cardiovascular disorders; anticholesterol agents; anticancer agents |
| 01/20/2005 | US20050014802 Prevent reproduction of virus; antitumor agents |
| 01/20/2005 | US20050014753 Antitumor agents |
| 01/20/2005 | US20050014749 Piperazine derivatives and methods of use |
| 01/20/2005 | US20050014746 compounds which bind to the interaction-domain (I-domain) of LFA-1, thus interrupting endothelial cell-leukocyte adhesion by blocking the interaction of LFA-1 with ICAM-1, ICAM-3, and other adhesion molecules |
| 01/20/2005 | US20050014700 Cbi analogues of cc-1065 and the duocarmycins |
| 01/20/2005 | US20050014678 Novel triazine-based detoxification agents and their use |
| 01/20/2005 | DE10329457A1 New 1,2-bis-phenylaminocarbonyl-pyrrolidine derivatives, useful for treating or preventing e.g. thrombosis, myocardial infarct and arteriosclerosis, are inhibitors of coagulation factor Xa |
| 01/20/2005 | DE102004014061A1 Amid-substituierte 1,2,4-Triazin-5(2H)-one Amide substituted 1,2,4-triazine-5 (2H) -ones |
| 01/20/2005 | CA2532068A1 Pyrrole-2, 5-dithione derivatives as liver x receptor modulators |
| 01/20/2005 | CA2531856A1 Benzimidazole carboxamides as raf kinase inhibitors |
| 01/20/2005 | CA2531751A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 01/20/2005 | CA2530737A1 Cck-1 receptor modulators |
| 01/20/2005 | CA2530450A1 5-substituted quinazolinone derivatives |
| 01/20/2005 | CA2530312A1 Arylamine-substituted quinazolinone compounds |
| 01/20/2005 | CA2529622A1 Indolinone hydrazides as c-met inhibitors |
| 01/20/2005 | CA2528626A1 Indoles useful in the treatment of inflammation |
| 01/20/2005 | CA2528336A1 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 01/19/2005 | EP1498417A1 Heterocyclic amide derivatives |
| 01/19/2005 | EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2005 | EP1497351A1 Low-viscosity polyisocyanate composition having high functionality and method for preparing same |
| 01/19/2005 | EP1497282A2 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4 protease |
| 01/19/2005 | EP1497281A2 Azole derivatives as antifungal agents |
| 01/19/2005 | EP1497280A1 Indol-2-ones as selective inhibitors of cyclooxygenase-2 |
| 01/19/2005 | EP1497279A2 Substituted indoles and their use as 5ht-reuptake inhibitors and as 5ht ligands |
| 01/19/2005 | EP1497278A1 Heterocyclic amide derivatives as cytokine inhibitors |
| 01/19/2005 | EP1497240A1 Non-heating clay composites for building materials |
| 01/19/2005 | EP1497019A1 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 01/19/2005 | EP1496906A1 Inhibitors of akt activity |
| 01/19/2005 | EP1496896A1 Inhibitors of akt activity |
| 01/19/2005 | EP1496892A2 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/19/2005 | EP1287018B1 Thrombin inhibitors |
| 01/19/2005 | EP0831813B1 Methods of inhibiting pneumocystis carinii pneumonia and compounds useful therefor |
| 01/19/2005 | CN1568323A Activator for peroxisome proliferator-activated receptor delta |
| 01/19/2005 | CN1568187A 2H-2, 3-dinitrogen phenodiazine-1-ketone and using method thereof |
| 01/19/2005 | CN1568185A Compounds effecting glucokinase |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1566091A Molindone derivatives and use for preparing antineoplastic medicine thereof |
| 01/19/2005 | CN1185250C Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/19/2005 | CN1185242C Ligand and complex for catalytically bleaching substate |
| 01/19/2005 | CN1185230C N-substituted carbamoyloxyalkyl-azolium derivs. |
| 01/19/2005 | CN1185229C 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta |
| 01/19/2005 | CN1185213C Azetidine derivatives, preparation and pharmaceutical compositions thereof |
| 01/18/2005 | US6844443 Hypotensive agents; cardiovascular disorders |
| 01/18/2005 | US6844439 Process for the preparation of imidazole compounds |
| 01/18/2005 | US6844347 Substituted 4-amino-2aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 01/18/2005 | US6844342 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
| 01/13/2005 | WO2005003118A1 Amide-substituted 1,2,4-triazin-5(2h)-ones for the treatment of chronically inflammatory diseases |
| 01/13/2005 | WO2005003103A2 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases |
| 01/13/2005 | WO2005003102A1 Methods of preparation of dehydro-diketopiperazines in liquid phase or of solid supported phase |
| 01/13/2005 | WO2005003100A2 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| 01/13/2005 | WO2005003099A2 Pyrimidines useful as modulators of voltage-gated ion channels |
| 01/13/2005 | WO2005003097A1 Cis-2,4,5-triaryl-imidazolines |
| 01/13/2005 | WO2005002575A1 Cis-imidazolines as mdm2 inhibitors |
| 01/13/2005 | WO2005002503A2 Asymmetric benzimidazoles and related compounds as potassium channel modulators |
| 01/13/2005 | WO2004099134A3 Glutaminyl based dp iv-inhibitors |
| 01/13/2005 | WO2004092130A3 N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders |
| 01/13/2005 | WO2004078943A3 Alternative heterocycles for dna recognition |
| 01/13/2005 | WO2004078744A3 Urea derivatives and their use as vanilloid receptor antagonists in the treatment of pain |
| 01/13/2005 | WO2004076406A3 Losartan potassium polymorphs and process for the preparation thereof |
| 01/13/2005 | WO2004072047A8 Indoles, benzimidazoles or naphhimidazoles as histone deacetylase (hdac) inhibitors |
| 01/13/2005 | WO2004064764A3 Substituted alkyl amido piperidines |
| 01/13/2005 | WO2004050035A3 Benzimidazoles and analogs thereof as antivirals |
| 01/13/2005 | US20050010031 2-(S)-{3-(S)-allyl-4-[2-(R)-amino-3-(4-fluorophenyl)propionyl]-2-oxo-piperazin-1-yl}-N-methyl-3-naphthalen-2-yl-propionamide for example; various diseases and disorders including controlling appetite and treating diabetes |
| 01/13/2005 | US20050009900 3-Substituted with a heterocyclic group, e.g., 2-Chloro-5-[1-(2,3-dihydroxy-propyl)-5-methyl-1H-pyrazol-3-yl]-N-(1-hydroxy-cycloheptylmethyl)-benzamide; treatment of IL-1 mediated disorders, including osteo- and rheumatoid arthritis, allergies, asthma, COPD, cancer, and reperfusion or ischemia in stroke |
| 01/13/2005 | US20050009898 New substituted indolinones, their manufacture and their use as medicaments |
| 01/13/2005 | US20050009894 Benzimidazole derivatives and their use as KDR kinase protein inhibitors |
| 01/13/2005 | US20050009876 Indazole compounds, compositions thereof and methods of treatment therewith |
| 01/13/2005 | US20050009867 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 01/13/2005 | US20050009853 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 01/13/2005 | US20050009840 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer |